mdxhealth.com - MDXH Forward Price-to-Revenue Multiple

MDxHealth Inc. (MDXH) - corporate logo

MDxHealth SA is implementing AI and robotics for tumor marker analysis while maintaining physician oversight. Stable management with an excellent reputation is steering the business toward profitability through sales growth. The Belgian-American leadership is effectively expanding insurance coverage. The forward P/S trend clearly demonstrates the dynamics of market expectations, and the 0.10 indicator confirms the current valuation of capitalization relative to future earnings.

mdxhealth.com - MDXH Forward Price to Sales (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for MDxHealth, Inc. (MDXH)

- current price and projected stock value:
Stock Price MDxHealth|MDXH - Broker Consensus Forecast
- issuer market value details:
Market Valuation MDxHealth, Inc.|MDXH - Business Value
- business book valuation details:
Book Value per Share MDxHealth SA|MDXH - Accounting Value of Company|Market Capitalization to Book Value Ratio mdxhealth.com|MDXH - Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital MDxHealth SA|MDXH - Long-Term Debt to Capital|Short-Term Debt to Equity MDxHealth SA|MDXH - Company Debts|Debt to Book Value MDxHealth, Inc.|MDXH - Amount of Long-Term Liabilities|Company Short-Term Debts MDxHealth SA|Quick Liquidity Indicator mdxhealth.com
- financial results and valuation multiples details:
MDXH - Final Profit|Expected Profit MDxHealth SA|MDXH - Business Payback Period|Forward P/E Multiple MDxHealth Inc.|MDXH - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MDxHealth, Inc.|MDXH - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) MDxHealth SA|MDXH - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months mdxhealth.com|MDXH - Earnings per share growth this year|Earnings growth forecast for next year MDxHealth SA
- company sales and revenue statistics:
MDXH - Company Sales Revenue|Company Projected Revenue MDxHealth|MDXH - Market Cap to Revenue|Forward P/S Multiple MDxHealth, Inc.
Summary company analytics:MDxHealth (MDXH)
Product sample of MDxHealth SA

The forward P/S reflects the market value of MDxHealth SA (MDXH) relative to expected revenue volumes, allowing for the real-time tracking of asset revaluation between quarterly reports. For MDxHealth SA (MDXH), whose revenues depend on the demand for molecular prostate cancer diagnostics, the estimated forward P/S helps assess the extent to which current capitalization aligns with the potential for expanding the use of their tests in urology.

Competing companies

Forward P/S Multiple A (Agilent)|DGX: Market Cap to Projected Revenue|ILMN: Forward Price-to-Revenue Multiple|EXAS (Exact Sciences Inc.) - Market Cap to Projected Revenue|RVTY: Forward P/S Multiple|bio-rad.com - Forward Price to Sales|NNNN (Anbio) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Sotera Health Corp SHC|Forward P/S Multiple QDEL|Forward P/S Multiple OPKO Health Corp. (OPK)|Price-to-Projected Revenue Ratio CareDx, Inc CDNA|maravai.com - Price-to-Projected Revenue Ratio|FLGT: Forward Price-to-Revenue Multiple|Standard BioTools Inc - Price to Expected Revenue Ratio|CTKB: Forward P/S Multiple|OraSure Corp - Forward Price to Sales|Forward Price-to-Revenue Multiple XGN|LUCD: Forward Price to Sales|Price-to-Projected Revenue Ratio Prenetics Global (PRE)|Market Cap to Expected Sales Ratio imdxinc.com|Forward P/S Multiple TRIB (Trinity Biotech)|Forward P/S Multiple ProPhase Labs Corp PRPH|AIMD - Price-to-Projected Revenue Ratio|codiagnostics.com (CODX) - Forward Price-to-Revenue Multiple|HSCS: Forward P/S Multiple|Market Cap to Projected Revenue BMRA|Forward Price-to-Revenue Multiple CDIO|Market Cap to Projected Revenue ONCO (Onconetix Corporation)|Forward P/S Multiple VRAX|BJDX (bluejaydx.com) - Forward Price to Sales|Price-to-Projected Revenue Ratio Aspira Women's Health Inc. AWH|AXDX - Forward Price-to-Revenue Multiple|centogene.com - Forward P/S Multiple|Market Cap to Future Revenue Ratio Enzo Biochem, Inc.|FRES: Forward P/S Multiple|Market Cap to Projected Revenue GENE|ME (23andMe) - Forward P/S Multiple|Forward P/S Multiple Psychemedics Corp.